🇺🇸 FDA
Patent

US 10155003

Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

granted A61KA61K31/05A61K31/19

Quick answer

US patent 10155003 (Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer) held by The Board of Regents of the University of Texas System expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/05, A61K31/19, A61K31/56, A61K9/0053